Lion Street Advisors LLC Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Lion Street Advisors LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 722 shares of the healthcare conglomerate’s stock after selling 219 shares during the quarter. Lion Street Advisors LLC’s holdings in UnitedHealth Group were worth $365,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group during the third quarter worth about $27,000. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $32,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter worth $37,000. Finally, Friedenthal Financial purchased a new stake in shares of UnitedHealth Group in the third quarter valued at about $51,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of UNH opened at $539.50 on Thursday. The firm has a market capitalization of $496.49 billion, a price-to-earnings ratio of 34.81, a PEG ratio of 1.48 and a beta of 0.61. The firm’s fifty day simple moving average is $533.81 and its 200-day simple moving average is $564.94. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the company earned $5.83 EPS. The business’s quarterly revenue was up 6.8% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent analyst reports. Morgan Stanley decreased their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Truist Financial cut their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. UBS Group lowered their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.